Suven Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on Monday, the February 6, 2023 at 11:30 am at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No. 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider and approve the following matter(s): To consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the third quarter and nine months ended December 31, 2022 and related matters. Further informed that, Trading Window for dealing in the securities of the company is already closed from 01st January, 2023 as per PIT Code of the Company. Trading window will be opened from 10th February, 2023.
The above information is a part of company’s filings submitted to BSE.
